ZTS
Stock Details
ZTS is Zoetis Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 169.91$. Average daily volumn in 3 months 2.27M. Market cap 82.18B
Stock symbol : ZTS. Exchange : NYSE. Currency : USD Lastest price : 174.61$. Total volume : 3.01M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Zoetis Inc. (ZTS)
Last Price
174.61$Change
5.44Volume
3.01M
| Previous Close | 169.17 |
| Open | 172.00 |
| Day Range | 171.39-174.68 |
| Bid | 173.67 x 1.3k |
| Ask | 173.66 x 1k |
| Volume | 3.01M |
| Average Volume | 2.27M |
| Market Cap | 82.18B |
| Beta | 0.77 |
| 52 Week Range | 154.18-249.27 |
| Trailing P/E | 40.06 |
| Foward P/E | 30.26 |
| Dividend (Yield %) | 0.80% |
| Ex-Dividend Date | 2022-07-20 |
Financial Details
Organization
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or ... induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Market Cap:
82.18BRevenue:
7.78BTotal Assets:
13.9BTotal Cash:
3.48B
News about "Zoetis Inc."
Brookstone Capital Management Reduces Stock Position in Zoetis Inc. (NYSE:ZTS)
Source from : Defense World - 22 hours ago
Brookstone Capital Management lessened its holdings in Zoetis Inc. (NYSE:ZTS – Get Rating) by 12.3% during the first quarter, according to its most recent disclosure with the SEC. The institutional ...See details»
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Has $264,000 Stock Holdings in Zoetis Inc. (NYSE:ZTS)
Source from : ETF Daily News - 1 days ago
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH decreased its stake in Zoetis Inc. (NYSE:ZTS – Get Rating) by 40.5% in the 1st quarter, according to the company in its most recent disclosure with the ...See details»
Zoetis Completes Acquisition of Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions
Source from : Associated Press - 3 days ago
(NYSE:ZTS) today announced the completion of its acquisition of Basepaws, a privately held petcare genetics company, w ...See details»
Zoetis completes Basepaws acquisition
Source from : NJBIZ - 2 days ago
Parsippany-based Zoetis Inc. completed its acquisition of Basepaws, a privately held pet care genetics company based in Los Angeles.See details»
Zoetis Inc.: Discounted price offers buying opportunity
Source from : Yahoo Finance - 8 days ago
Zoetis Inc., a 2013 spinoff from Pfizer, focuses on the development, manufacture and commercialization of animal health vaccines and medicines, including parasiticides, anti-infectives ...See details»
Here’s Why Baron Funds Remains Optimistic in Zoetis (ZTS)
Source from : Insider Monkey - 10 days ago
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.See details»
CNBC's Final Trades: ChargePoint Holdings, Energy Puts, And These Pharma And Health Care Stocks To Buy
Source from : Benzinga.com - 1 days ago
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE: ZTS) is a pharma company “without all the problems ...See details»
Zoetis Inc Class A - Stock Valuation ZTS
Source from : Morningstar%2c Inc. - 6 days ago
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»
Zoetis Inc. Class A
Source from : TheStreet.com - 13 days ago
ZOETIS INC's gross profit margin for the first quarter of its fiscal year 2022 is essentially unchanged when compared to the same period a year ago. The company has grown sales and net income ...See details»
Zoetis launches Improvest for estrus suppression in market gilts
Source from : National Hog Farmer - 11 days ago
Zoetis recently announced that the U.S. Food and Drug Administration (FDA) has approved a label extension of Improvest for use in market gilts. By temporarily suppressing estrus in gilts intended for ...See details»
9 Dividend Stocks to Buy According to Richard Hamm’s Bristol Gate Capital
Source from : Insider Monkey - 12 days ago
In this article, we discuss 9 dividend stocks to buy according to Richard Hamm’s Bristol Gate Capital. You can skip our detailed analysis of the hedge fund’s past performance, and go directly to read ...See details»
Zoetis to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
Source from : Yahoo Finance - 13 days ago
PARSIPPANY, N.J., June 10, 2022--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on Monday, June 13, 2022. Wetteny Joseph ...See details»
Zoetis releases 2021 sustainability update
Source from : efeedlink.com - 13 days ago
Zoetis releases 2021 sustainability update. Zoetis published on June 8 its 2021 Sustainability Progress Update describing the company's progress toward achieving it ...See details»
Great Plains Zoo vaccinating animals for the coronavirus
Source from : Houston Chronicle - 11 days ago
A global animal health company, Zoetis, has developed an experimental vaccine for COVID-19 and is working with zoos across the country to distribute its limited supply to vaccinate the most at ...See details»